Inhibition of the growth of Toxoplasma gondii in immature human dendritic cells is dependent on the expression of TNF-α receptor 2

Journal of Immunology

Volumn 173, Issue 5, 2004, Pages 3366-3374

  Giese, Anja ^a,b   Stuhlsatz, Silke ^a   Däubener, Walter ^a   MacKenzie, Colin R ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF OLDENBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; EX VIVO STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 4344657748     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.5.3366     Document Type: Article

References (34)

1. Suzuki, Y., M. A. Orellana, R. D. Schreiber, and J. S. Remington. 1988. Interferon-γ: the major mediator of resistance against Taxoplasma gondii. Science 240:516.
2. Adams, L. B., J. B. Hibbs, Jr., R. R. Taintor, and J. L. Krahenbuhl. 1990. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii: role for synthesis of inorganic nitrogen oxides from L-arginine. J. Immunol. 144:2725.
3. Murray, H. W., and Z. A. Cohn. 1979. Macrophage oxygen-dependent antimicrobial activity. I. Susceptibility of Toxoplasma gondii to oxygen intermediates. J. Exp. Med. 150:938.
4. Dimier, I. H., and D. T. Bout. 1998. Interferon-γ-activated primary enterocytes inhibit Toxoplasma gondii replication: a role for intracellular iron. Immunology 94:488.
5. Pfefferkorn, E. R. 1984. Interferon γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. USA 81:908.
6. Murray, H. W., and R. F. Teitelbaum. 1992. L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J. Infect. Dis. 165:513.
7. Peterson, P. K., G. Gekker, S. Hu, and C. C. Chao. 1995. Human astrocytes inhibit intracellular multiplication of Toxoplasma gondii by a nitric oxide-mediated mechanism. J. Infect. Dis. 171:516.
8. Schneemann, M., G. Schoedon, S. Hofer, N. Blau, L. Guerrero, and A. Schaffner. 1993. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167:1358.
9. MacKenzie, C. R., R. Langen, O. Takikawa, and W. Däubener. 1999. Inhibition of indoleamine 2,3-dioxygenase in human macrophages inhibits interferon-γ-induced bacteriostasis but does not abrogate toxoplasmastasis. Eur. J. Immunol. 29:3254.
10. Murray, H. W., B. Y. Rubin, S. M. Carriero, A. M. Harris, and E. A. Jaffee. 1985. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii. J. Immunol. 134:1982.
11. Aline, F., D. Bout, and I. Dimier-Poisson. 2002. Dendritic cells as effector cells: γ interferon activation of murine dendritic cells triggers oxygen-dependent inhibition of Toxoplasma gondii replication. Infect. Immun. 70:2368.
12. Remington, J. S., and G. Desmonts. 1976. Toxoplasmosis. In Infectious Diseases of the Fetus and Newborn Infant. J. S. Remington and J. O. Klein, eds. W. B. Saunders Co., Philadelphia, pp. 191-332
13. Channon, J. Y., R. M. Seguin, and L. H. Kasper. 2000. Differential infectivity and division of Toxoplasma gondii in human peripheral blood leukocytes. Infect. Immun. 68:4822.
14. Wilson, C. B., and J. S. Remington. 1979. Activity of human blood leukocytes against Toxoplasma gondii. J. Infect. Dis. 140:890.
15. Langermans, J. A., M. E. Van der Hulst, P. H. Nibbering, P. S. Hiemstra, L. Fransen, and R. Van Furth. 1992. IFN-γ-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α J. Immunol. 148:568.
16. Deckert-Schlüter, M., H. Bluethmann, A. Rang, H. Hof, and D. Schluter. 1998. Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis. J. Immunol. 160:3427.
17. Yap, G. S., T. Scharton-Kersten, H. Charest, and A. Sher. 1998. Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. J. Immunol. 160:1340.
18. Belloni, A., I. Villena, J. E. Gomez, H. Pelloux, A. Bonhomme, M. Guenounou, J. M. Pinon, and D. Aubert. 2003. Regulation of tumor necrosis factor α and its specific receptors during Toxoplasma gondii infection in human monocytic cells. Parasitol. Res. 89:207.
19. Tartaglia, L. A., D. Pennica, and D. V. Goeddel. 1993. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 268:18542.
20. Gubbels, M. J., C. Li, and B. Striepen. 2003. High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein. Antimicrob. Agents Chemother. 47:309.
21. Pfefferkorn, E. R., and L. C. Pfefferkorn. 1977. Specific labeling of intracellular Toxoplasma gondii with uracil. J. Protozool. 24:449.
22. Deckert-Schluter, M., A. Rang, D. Weiner, S. Huang, O. D. Wiestler, H. Hof, and D. Schluter. 1996. Interferon-γ receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation. Lab. Invest. 75:827.
23. Scharton-Kersten, T. M., T. A. Wynn, E. Y. Denkers, S. Bala, E. Grunvald, S. Hieny, R. T. Gazzinelli, and A. Sher. 1996. In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Taxoplasma gondii while failing to control acute infection. J. Immunol. 157:4045.
24. Nagineni, C. N., K. Pardhasaradhi, M. C. Martins, B. Detrick, and J. J. Hooks. 1996. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect. Immun. 64:4188.
25. Däubener, W., V. Posdziech, U. Hadding, and C. R. MacKenzie. 1999. Inducible an anti-parasitic effector mechanisms in human uroepithelial cells: tryptophan degradation vs. NO production. Med. Microbiol. Immunol. 187:143.
26. McLeod, R., R. Estes, D. G. Mack, and E. G. McLeod. 1983. Effects of human alveolar macrophages and peripheral blood monocytes on Toxoplasma gondii. J. Infect. Dis. 147:957.
27. Channon, J. Y., and L. H. Kasper. 1996. Toxoplasma gondii-induced immune suppression by human peripheral blood monocytes: role of γ interferon. Infect. Immun. 64:1181.
28. Subauste, C. S., and M. Wessendarp. 2000. Human dendritic cells discriminate between viable and killed Toxoplasma gondii tachyzoites: dendritic cell activation after infection with viable parasites results in CD28 and CD40 ligand signaling that controls IL-12-dependent and -independent T cell production of IFN-γ. J. Immunol. 165:1498.
29. Derouich-Guergour, D., D. Aldebert, I. Vigan, E. Jouvin-Marche, P. N. Marche, D. Aubert, P. Ambroise-Thomas, and H. Pelloux. 2002. Toxoplasma gondii infection can regulate the expression of tumor necrosis factor-α receptors on human cells in vitro. Parasite Immunol. 24:271.
30. Stoelcker, B., T. Hehlgans, K. Weigl, H. Bluethmann, G. E. Grau, and D. N. Mannel. 2002. Requirement for tumor necrosis factor receptor 2 expression on vascular cells to induce experimental cerebral malaria. Infect. Immun. 70:5857.
31. Piguet, P. F., C. D. Kan, and C. Vesin. 2002. Role of the tumor necrosis factor receptor 2 (TNFR2) in cerebral malaria in mice. Lab. Invest. 82:1155.
32. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457.
33. Vieira, L. Q., M. Goldschmidt, M. Nashleanas, K. Pfeffer, T. Mak, and P. Scott. 1996. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J. Immunol. 157:827.
34. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, and B. R. Bloom. 1995. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561.